Brief: Kaleido Biosciences Presents Data For Microbiome Metabolic Therapy KB174 For Hepatic Encephalopathy
27/08/2020 12:42
Aug 27 (Reuters) - Kaleido Biosciences Inc KLDO.O :
* KALEIDO BIOSCIENCES ANNOUNCES PRESENTATION OF DATA FOR
MICROBIOME METABOLIC THERAPY KB174 FOR HEPATIC ENCEPHALOPATHY AT
THE DIGITAL INTERNATIONAL LIVER CONGRESS™ (EASL)
Source text for Eikon: ID:nGNX4bkfGh
Further company coverage: KLDO.O
((Reuters.Briefs@thomsonreuters.com;))